Dimitris Moulavasilis is the Group Chief Executive Officer of M42, a global health champion powered by artificial intelligence, technology and genomics to transform care for all. With over 30 years of international experience in healthcare services and medical technology, Dimitris is known for driving innovation and excellence across the industry.
In addition to his current role, Dimitris also serves as the Chief Executive Officer of M42’s Global Patient Care platform, a central component of M42’s mission to transform healthcare on a global scale. Under his leadership, the Global Patient Care platform has integrated M42’s UAE and international healthcare assets, consisting of 480 clinics across 26 countries, and serving 15 million patients annually. The platform delivers comprehensive healthcare services, including Renal Care, Outpatient and Chronic Disease Management, Diagnostics, Women's & Children's Health, Specialty Surgery, and Long-Term Care.
Dimitris served as the Chief Executive Officer of Diaverum, one of the world’s leading global renal care providers, since 2018, spearheading major digital transformation initiatives, focusing on digitizing clinical workflows and integrating machine learning technologies to provide high-quality renal care at scale. Before this, he was the Group Chief Executive Officer at Affidea, a leading pan-European provider of imaging, outpatient and cancer care services, where he led the company from 2012 to 2018. Earlier in his career, Dimitris held senior sales management roles at GE Healthcare, specializing in ultrasound systems and medical imaging devices.
A passionate advocate for digital healthcare transformation, Dimitris is committed to leveraging AI and technology to democratize and revolutionize healthcare, ensuring high-quality, personalized care is accessible to all.
